AirSculpt Technologies, Inc. (AIRS)

Market Cap	367.55M
Revenue (ttm)	188.78M
Net Income (ttm)	-7.79M
Shares Out	57.88M
EPS (ttm)	-0.14
PE Ratio	n/a
Forward PE	29.30
Dividend	n/a
Ex-Dividend Date	n/a

Volume	125,265
Open	6.36
Previous Close	6.38
Day's Range	6.16 - 6.51
52-Week Range	2.92 - 9.20
Beta	1.62
Analysts	Hold
Price Target	5.50 (-13.39%)
Earnings Date	Nov 8, 2024

About AIRS

AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. The company offers AirSculpt, a next-generation body contouring procedure that removes unwanted fat and tightens skin in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool....

• Industry: Medical Care Facilities
• Sector: Healthcare
• IPO Date: Oct 29, 2021
• Employees: 381
• Stock Exchange: NASDAQ
• Ticker Symbol: AIRS
• Website: https://elitebodysculpture.com

Financial Performance

In 2023, AirSculpt Technologies's revenue was $195.92 million, an increase of 16.07% compared to the previous year's $168.79 million. Losses were -$4.48 million, -69.49% less than in 2022.

Analyst Forecast

According to 3 analysts, the average rating for AIRS stock is "Hold." The 12-month stock price forecast is $5.5, which is a decrease of -13.39% from the latest price.

Price Target

$5.5

(-13.39% downside)

Analyst Consensus: Hold